Clinical Trial Update: Rollover Study Of Lapatinib In Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 rollover study of lapatinib in cancer patients, including breast cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED